Annual report pursuant to Section 13 and 15(d)

Balance Sheets

v3.24.1.u1
Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash $ 6,989,424 $ 13,468,026
Acquired patents, net 5,391 9,003
Total assets 6,994,815 13,477,029
Current liabilities    
Accounts payable & accrued interest 256,317 220,845
Unreimbursed expenses 38,089 42,060
Total current liabilities 294,406 262,905
Total liabilities 294,406 262,905
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,848,165 shares issued and outstanding as of December 31, 2023 and 2022 12,848 12,848
Additional paid-in capital 57,052,130 54,674,042
Accumulated deficit (50,364,569) (41,472,766)
Total stockholders’ equity 6,700,409 13,214,124
Total liabilities and stockholders’ equity $ 6,994,815 $ 13,477,029